Controlled Clinical Comparison of BACTEC Plus Anaerobic/F to Standard Anaerobic/F as the Anaerobic Companion Bottle to Plus Aerobic/F Medium for Culturing Blood from Adults

Abstract

To determine the optimal anaerobic companion bottle to pair with BACTEC Plus Aerobic/F medium for recovery of pathogenic microorganisms from adult patients with bacteremia and fungemia, we compared Plus Anaerobic/F bottles with Standard Anaerobic/F bottles, each of which was filled with 4 to 6 ml of blood. The two bottles were paired with a Plus Aerobic/F bottle filled with 8 to 12 ml of blood. A total of 14,011 blood culture sets were obtained. Of these, 11,583 sets were received with all three bottles filled adequately and 12,257 were received with both anaerobic bottles filled adequately. Of 818 clinically important isolates detected in one or both adequately filled anaerobic bottles, significantly more staphylococci (P < 0.001), streptococci (P < 0.005), Escherichia coli isolates (P < 0.02), Klebsiella pneumoniae isolates (P < 0.005), and all microorganisms combined (P < 0.001) were detected in Plus Anaerobic/F bottles. In contrast, significantly more anaerobic gram-negative bacilli were detected in Standard Anaerobic/F bottles (P < 0.05). Of 397 unimicrobial episodes of septicemia, 354 were detected with both pairs, 30 were detected with Plus Aerobic/F–Plus Anaerobic/F pairs only, and 13 were detected with Plus Aerobic/F–Standard Anaerobic/F pairs only (P < 0.05). Significantly more episodes of bacteremia caused by members of the family Enterobacteriaceae (P < 0.05) and aerobic and facultative gram-positive bacteria (P < 0.025) were detected with Plus Anaerobic/F bottles only. In a paired-bottle analysis, 810 of 950 isolates were recovered from both pairs, 90 were recovered from Plus Aerobic/F–Plus Anaerobic/F pairs only, and 50 were recovered from Plus Aerobic/F–Standard Anaerobic/F pairs only (P < 0.001). Paired Plus Aerobic/F–Plus Anaerobic/F bottles yielded significantly more staphylococci (P < 0.001), streptococci (P < 0.05), and members of the family Enterobacteriaceae (P <0.001). We conclude that Plus Anaerobic/F bottles detect more microorganisms and episodes of bacteremia and fungemia than Standard Anaerobic/F bottles as companion bottles to Plus Aerobic/F bottles in the BACTEC 9240 blood culture system.

During the past decade, several investigators have noted a declining incidence of bacteremia caused by anaerobic organisms (4, 16, 27; J. W. Gray and S. J. Pedler, Letter, Am. J. Med. 93:706–707, 1992). During the same period there has been a reported increase in the proportion of blood cultures that yield pathogenic fungi (16, 27). Because of these observations, some investigators have questioned the practice of routinely inoculating half of the collected blood volume into anaerobic blood culture bottles, suggesting that overall yield may be increased by culturing all of the blood in aerobic bottles, restricting use of anaerobic blood cultures to patients in whom anaerobic bacteremia is likely to occur (5, 7, 14, 16, 19, 23, 30). Other investigators have suggested that anaerobic blood cultures are no longer as helpful clinically because bacteremia caused by anaerobic organisms occurs in predictable clinical scenarios, the results do not affect patient care, or empiric therapy often is not changed on the basis of the results of blood cultures (7, 11, 19, 23). Published data do, however, indicate that the incidence of bacteremia caused by anaerobic organisms has not decreased (or has even increased) in some patient populations, that bacteremia caused by anaerobic organisms can occur in a clinically unpredictable manner, and that anaerobic blood culture results affect therapeutic decisions (3, 6, 17, 21; W. R. Gransden, S. J. Eykyn, and I. Phillips, Letter, Rev. Infect. Dis. 13:1255–1256, 1991; Gray and Pedler, Letter; T. V. Riley and M. A. Aravena, Letter, Eur. J. Clin. Microbiol. Infect. Dis. 14:73–75, 1995). Therefore, some investigators continue to advocate routine use of anaerobic blood culture bottles (3, 6; Gray and Pedler, Letter). The decision as to which approach to take will depend, in part, upon the results of controlled clinical trials that compare the relative yields of aerobic and anaerobic blood culture bottles. For such trials to be meaningful, it will be necessary to compare the best aerobic and anaerobic bottles. To determine which anaerobic formulation is best, controlled clinical trials are needed that compare the different anaerobic formulations available with each blood culture system.

The BACTEC 9240 system (Becton Dickinson BioSciences, Sparks, Md.) is a continuous monitoring blood culture system that uses several medium formulations. Although the aerobic formulations have been studied extensively, the anaerobic formulations have not been evaluated to the same degree in controlled clinical trials. In the study described here, we compared the BACTEC Plus Anaerobic/F bottle with the Standard Anaerobic/F bottle for recovery of bacteria and fungi from adult patients. The two anaerobic bottles were paired with the Plus Aerobic/F bottle, as that bottle has previously been shown to recover pathogenic microorganisms with yields superior to those from non-resin-containing bottles (2, 10, 24) and equivalent to those from other high-volume resin-containing bottles (9, 18, 22).

MATERIALS AND METHODS

Blood culture and collection.

Blood samples for culture were collected from adult patients hospitalized at Duke University Medical Center (DUMC), Robert Wood Johnson University Hospital (RWJUH), and Denver Health Medical Center (DHMC). Institutional review board approval was obtained prior to the study at each of the study sites. All blood cultures were performed per physician order as part of routine patient care. Venipuncture sites were disinfected with povidone iodine and allowed to dry. The povidone iodine was removed with isopropyl alcohol as a second disinfecting step. Up to 20 ml of blood was drawn from veins with a sterile needle and syringe. Needles were not changed prior to inoculation of blood culture bottles.

Adequacy of blood volume.

Upon receipt in the laboratories, the volume of blood inoculated into each bottle was assessed visually by comparison with known volume standards. Plus Aerobic/F bottles were categorized by the volume of fill as underfilled (<8 ml), adequately filled (8 to 12 ml), or overfilled (>12 ml). Plus Anaerobic/F bottles were similarly categorized by the volume of fill as underfilled (<4 ml), adequately filled (4 to 6 ml), or overfilled (>6 ml). All bottles were processed for patient care purposes, irrespective of the volume of blood contained within them.

Bottle processing.

All bottles were placed in the instrument (BACTEC 9240) and tested for 5 days according to the manufacturer's recommendations. Bottles flagged by an instrument as positive were removed from the instrument. An aliquot of the blood-broth mixture was removed from the bottle with a sterile needle and syringe. A portion was used for a Gram stain, and the remainder was subcultured onto solid plate media according to the results of the Gram stain. Subsequent isolation and identification of the microbes and antimicrobial susceptibility testing were performed by standard techniques (15).

Clinical assessment.

All isolates recovered were reviewed by an infectious diseases physician or a pathologist and were categorized as clinically important, indeterminate as the cause of sepsis, or a contaminant. The assessments were made in accord with published criteria (27). An episode of bacteremia or fungemia was defined as a period that began with the first positive blood culture and that ended when 7 days (2 days for coagulase-negative staphylococci) had passed without another blood sample positive by culture for the same microorganism, regardless of whether samples negative by culture were drawn in the intervening days. When a second clinically important isolate was detected within 3 days of detection of the first isolate, the episode was categorized as polymicrobial.

Data analysis.

Data were forwarded to one study site (DUMC), where they were entered into a database (Paradox; Corel, Farmingdale, N.Y.). Comparison of recovery rates was made by the chi-square test with Yates' correction when the number of samples was less than 20 (13). Comparison of the mean speeds of detection of microbial growth was made by the two-tailed t test. A cutoff of 72 h was used in these comparisons because (i) most, if not all, pathogenic microorganisms are recovered within this time frame, (ii) most microorganisms recovered thereafter are contaminants, and (iii) data from outliers (i.e., pathogenic microorganisms with delayed growth) would likely skew the means.

RESULTS

A total of 12,257 blood culture sets were received with both anaerobic bottles filled adequately (8,966 collected at DUMC, 2,344 collected at RWJUH, and 947 collected at DHMC), yielding 818 clinically important isolates. As shown in Table 1, 461 were recovered from both anaerobic bottles, 278 were recovered from Plus Anaerobic/F bottles only, and 79 were recovered from Standard Anaerobic/F bottles only (P < 0.001). Significantly more Staphylococcus aureus isolates (P < 0.001), coagulase-negative staphylococci (P < 0.001), streptococci (P < 0.005), Escherichia coli isolates (P < 0.02), and Klebsiella pneumoniae isolates (P < 0.005) were recovered from Plus Anaerobic/F bottles only. In contrast, significantly more gram-negative anaerobic bacteria were recovered from Standard Anaerobic/F bottles only (P < 0.05).

TABLE 1.

Comparative yields of clinically important bacteria and fungi from BACTEC Plus Anaerobic/F and Standard Anaerobic/F blood culture bottles

Microorganism	No. of isolates recovered from:			P
	Both bottles	Plus Anaerobic/F bottles only	Standard Anaerobic/F bottles only
Gram-positive cocci
Staphylococcus aureus	139	120	9	<0.001
Coagulase-negative staphylococci	61	54	10	<0.001
Enterococcib	51	16	14	NSa
Streptococcic	28	11	0	<0.005
Other gram-positive bacteriad	2	0	3	NS
Gram-negative bacilli
Escherichia coli	47	22	8	<0.02
Klebsiella pneumoniae	48	20	4	<0.005
Other Enterobacteriaceaee	50	9	5	NS
Nonfermentersf	13	9	4	NS
Anaerobic bacteria
Gram-positiveg	6	5	4	NS
Gram-negativeh	10	4	14	<0.05
Yeastsi	6	8	4	NS
All microorganisms	461	278	79	<0.001

^aNS, nonsignificant (P > 0.050). 

^bIncludes 53 Enterococcus faecalis, 21 Enterococcus faecium, and 6 Enterococcus durans isolates and 1 Enterococcus sp. 

^cIncludes 15 viridans group streptococci, 9 Streptococcus pneumoniae isolates, 8 group B streptococci, 4 group G streptococci, 2 nutritionally deficient streptococci, and 1 group A streptococcus. 

^dIncludes two Listeria monocytogenes isolates, one Aerococcus viridans isolate, and one Lactobacillus sp. 

^eIncludes 23 Serratia marcescens, 14 Enterobacter cloacae, 8 Klebsiella oxytoca, 6 Enterobacter aerogenes, 5 Proteus mirabilis, 3 Proteus vulgaris, and 3 Citrobacter diversus isolates, 1 Morganella morganii isolate, and 1 Salmonella sp. 

^fIncludes 16 Pseudomonas aeruginosa, 4 Pseudomonas fluorescens, 2 Achromobacter xylosoxidans subsp. xylosoxidans, and 2 Stenotrophomonas maltophilia isolates, 1 Acinetobacter baumanii isolate, and 1 Acinetobacter sp. 

^gIncludes six Clostridium septicum, three Clostridium tertium, two Clostridium innocuum, and two Clostridium spp. isolates and one isolate each of Clostridium perfringens and Clostridium ramosum. 

^hIncludes 11 Bacteroides fragilis, 5 Bacteroides thetaiotaomicron, 2 Bacteroides oris-Bacteroides buccae, 2 Bacteroides spp., 2 Fusobacterium nucleatum, and 2 Porphyromonas loescheii isolates, 1 isolate each of Bacteroides fragilis group, Bacteroides intermedius, and Bacteroides uniformis, and 1 Fusobacterium sp. 

ⁱIncludes eight Candida glabrata, seven Candida tropicalis, and three Candida albicans isolates. 

As shown in Table 2, the mean times to detection of microbial growth for clinically important microorganisms was shorter for Staphylococcus aureus (P < 0.001), coagulase-negative staphylococci (P < 0.001), anaerobic gram-negative bacilli (P < 0.04), and all microorganisms combined (P < 0.001) with Plus Anaerobic/F bottles.

TABLE 2.

Mean times to detection of microbial growth for clinically important microorganisms recovered within the first 72 h of incubation in Plus Anaerobic/F and Standard Anaerobic/F blood culture bottles

Microorganism	Avg (range) time (h) to detectiona		No. of bottles	P
	Plus Anaerobic/F bottles	Standard Anaerobic/F bottles
Gram-positive cocci
Staphylococcus aureus	14.6 (6.0–40.3)	17.6 (6.9–47.8)	131	<0.001
Coagulase-negative staphylococci	18.6 (5.7–44.2)	22.9 (6.2–65.0)	59	<0.001
Enterococci	15.0 (3.5–68.0)	14.5 (3.5–45.8)	51	NSb
Streptococci	11.3 (4.5–25.0)	12.3 (4.7–32.5)	28	NS
Gram-positive bacilli	27.3 (16.5–38.2)	25.3 (13.0–37.6)	2	NS
Gram-negative bacilli
Enterobacteriaceae	10.3 (2.0–37.5)	11.5 (2.0–66.1)	142	NS
Nonfermenters	11.2 (2.0–30.1)	12.7 (2.0–27.6)	13	NS
Anaerobic bacteria
Gram-positive	18.7 (9.1–41.2)	24.2 (9.1–52.8)	6	NS
Gram-negative bacilli	39.5 (24.5–65.9)	27.2 (18.6–55.7)	8	<0.04
Fungi	22.4 (14.2–43.4)	27.8 (14.0–47.7)	5	NS
All microorganisms	14.1 (2.0–68.0)	15.9 (2.0–66.1)	445	<0.001

^aA cutoff of 72 h was used to eliminate bias from cultures that became positive late in the incubation and testing cycle (i.e., outliers). 

^bNS, not significant (P > 0.05). 

A comparison of detection of septic episodes is shown in Table 3. Of 397 unimicrobial episodes of bacteria and fungemia, 354 were detected with both systems, 30 were detected with Plus Anaerobic/F bottles only, and 13 were detected with Standard Anaerobic/F bottles only (P < 0.05). Significantly more septic episodes caused by members of the family Enterobacteriaceae (P < 0.05) and aerobic and facultative gram-positive bacteria (P < 0.025) were detected with Plus Anaerobic/F bottles only.

TABLE 3.

Comparative detection of episodes of bacteremia and fungemia in Plus Anaerobic/F and Standard Anaerobic/F blood culture bottles

Episode	No. of episodes detected bya:			P
	Both sets	Plus sets only	Standard sets only
Aerobic and facultative microorganisms
Gram-positive microorganismsb	206	17	6	<0.025
Enterobacteriaceaed	86	10	2	<0.05
Other gram-negative bacillie	32	0	0	NSc
Anaerobic bacteriaf	6	3	3	NS
Yeastsg	24	0	2	NS
All episodes	354	30	13	<0.05

^aPlus sets consisted of a Plus Aerobic/F and Plus Anaerobic/F bottles; Standard sets consisted of Plus Aerobic/F and Standard Anaerobic/F bottles. 

^bIncludes 117 Staphylococcus aureus isolates, 53 coagulase-negative staphylococci, 21 Enterococcus faecalis isolates, 10 Enterococcus faecium isolates, 7 Streptococcus pneumoniae isolates, 6 viridans group streptococci, 3 group B streptococci, 2 group G streptococci, 2 Listeria monocytogenes isolates, 2 Bacillus spp., 1 Bacillus cereus isolate, 1 Lactobacillus sp., 1 Corynebacterium jeikeium isolate, 1 Enterococcus sp., 1 group A streptococcus, and 1 Aerococcus viridans isolate. 

^cNS, not significant (P > 0.050). 

^dIncludes 37 Escherichia coli, 32 Klebsiella pneumoniae, 8 Serratia marcescens, 7 Enterobacter cloacae, 5 Enterobacter aerogenes, and 4 Klebsiella oxytoca isolates and 1 isolate each of Citrobacter diversus, Citrobacter freundii, Morganella morganii, Pantoea agglomerans, and Proteus mirabilis. 

^eIncludes 16 Pseudomonas aeruginosa, 5 Acinetobacter baumanii, 5 Stenotrophomonas maltophilia, and 2 Burkholderia cepacia isolates and 1 isolate each of Acinetobacter lwoffi, Achromobacter xylosoxidans subsp. xylosoxidans, Burkholderia gladioli, and Haemophilus influenzae. 

^fIncludes six Bacteroides fragilis isolates, two Bacteroides thetaiotaomicron isolates, one Fusobacterium sp., one Bacteroides sp., one Clostridium septicum isolate, and one Clostridium sp. 

^gIncludes 13 Candida albicans, 6 Candida glabrata, 2 Cryptococcus neoformans, 2 Candida tropicalis, and 2 Candida parapsilosis isolates and 1 Histoplasma capsulatum isolate. 

Of the 12,257 sets, 11,583 sets were received with all three bottles filled adequately (8,469 collected at DUMC, 2,218 collected at RWJUH, and 896 collected at DHMC), yielding 950 clinically important isolates. In a comparison of the recovery of clinically important microorganisms in these paired bottle sets (i.e., Plus Aerobic/F bottles paired with either Plus Anaerobic/F or Standard Anaerobic/F bottles) (Table 4), significantly more Staphylococcus aureus isolates (P < 0.001), streptococci (P < 0.05), members of the family Enterobacteriaceae (P < 0.001), and all microorganisms combined (P < 0.001) were recovered from paired Plus Aerobic/F–Plus Anaerobic/F bottles.

TABLE 4.

Comparative yields of microorganisms from Plus Anaerobic/F versus Standard Anaerobic/F bottles paired with Plus Aerobic/F bottles

Episode	No. of isolates detected bya:			P
	Both sets	Plus sets only	Standard set only
Gram-positive cocci
Staphylococcus aureus	233	28	7	<0.001
Coagulase-negative staphylococci	113	15	8	NSb
Enterococcic	70	10	8	NS
Streptococcid	39	6	0	<0.05
Other gram-positive bacteriae	10	0	2	NS
Gram-negative bacteria
Enterobacteriaceaef	196	21	7	<0.001
Other gram-negative bacteriag	70	0	0	NS
Anaerobic bacteria
Gram-positiveh	7	4	3	NS
Gram-negativei	10	4	13	NS
Yeastsj	62	2	2	NS
All microorganisms	810	90	50	<0.001

^aPlus sets consisted of a Plus Aerobic/F and Plus Anaerobic/F bottles; Standard sets consisted of Plus Aerobic/F and Standard Anaerobic/F bottles. 

^bNS, Not significant (P > 0.05). 

^cIncludes 51 Enterococcus faecalis, 29 Enterococcus faecium, and 7 Enterococcus durans isolates and 1 Enterococcus sp. 

^dIncludes 16 viridans group streptococci, 12 Streptococcus pneumoniae isolates, 9 group B streptococci, 4 group G streptococci, 2 group A streptococci, and 2 nutritionally variant streptococci. 

^eIncludes four Listeria monocytogenes isolates, two Aerococcus viridans isolates, two Bacillus spp., one Bacillus cereus isolate, one Corynebacterium jeikeium isolate, one Lactobacillus sp., and one diphtheroid. 

^fIncludes 79 Escherichia coli, 78 Klebsiella pneumoniae, 22 Serratia marcescens, 15 Enterobacter cloacae, 8 Klebsiella oxytoca, 7 Enterobacter aerogenes, 4 Proteus mirabilis, 3 Proteus vulgaris, and 3 Citrobacter diversus isolates, 1 Citrobacter freundii isolate, 1 Enterobacter sp., 1 Morganella morganii isolate, 1 Pantoea agglomerans isolate, and 1 Salmonella sp. 

^gIncludes 35 Pseudomonas aeruginosa, 11 Acinetobacter baumanii, 6 Stenotrophomonas maltophilia, 5 Achromobacter xylosoxidans subsp. xylosoxidans, 4 Pseudomonas fluorescens, 2 Acinetobacter spp., and 2 Burkholderia cepacia isolates, 1 Burkholderia gladioli isolate, 1 Moraxella sp., 1 Pseudomonas sp., 1 Haemophilus influenzae isolate, and 1 Acinetobacter lwoffi isolate. 

^hIncludes six Clostridium septicum isolates, two Clostridium tertium isolates, two Clostridium spp., two Clostridium innocuum isolates, one Clostridium perfringens isolate, and one Clostridium ramosum isolate. 

ⁱIncludes 11 Bacteroides fragilis, 5 Bacteroides thetaiotaomicron, 2 Bacteroides oris-Bacteroides buccae, 2 Porphyromonas loescheii, and 2 Fusobacterium nucleatum isolates, 2 Bacteroides spp., 1 Bacteroides fragilis group isolate, 1 Bacteroides uniformis isolate, and 1 Fusobacterium sp. 

^jIncludes 27 Candida albicans, 16 Candida tropicalis, 11 Candida glabrata, 6 Candida parapsilosis, 3 Candida kefyr, and 2 Cryptococcus neoformans isolates and 1 Histoplasma capsulatum isolate. 

For patients receiving appropriate antimicrobial therapy at the time of blood culture (Table 5), significantly more Staphylococcus aureus isolates (P < 0.001), coagulase-negative staphylococci (P < 0.02), members of the family Enterobacteriaceae (P < 0.05), and all microorganisms combined (P < 0.001) were recovered from Plus Anaerobic/F bottles only. In contrast, there were no significant differences in microbial recovery for patients not receiving antimicrobial therapy at the time of blood culture (data not shown).

TABLE 5.

Comparative yields of microorganisms in Plus Anaerobic/F versus Standard Anaerobic/F bottles paired with Plus Aerobic/F bottles from patients on therapy

Episode	No. of episodes detected bya:			P
	Both sets	Plus sets only	Standard sets only
Gram-positive bacteria
Staphylococcus aureus	21	23	1	<0.001
Coagulase-negative staphylococci	12	8	0	<0.02
Other gram-positive bacteriab	11	7	4	NSc
Gram-negative bacteria
Enterobacteriaceaed	5	8	1	<0.05
Other gram-negative bacillie	1	0	0	NS
Anaerobic bacteriaf	2	5	5	NS
Yeastsg	11	1	0	NS
All microorganisms	63	52	11	<0.001

^aPlus sets consisted of a Plus Aerobic/F and Plus Anaerobic/F bottles; Standard sets consisted of Plus Aerobic/F and Standard Anaerobic/F bottles. 

^bIncludes 10 Enterococcus faecalis isolates, 4 group B streptococci, 2 Enterococcus faecium isolates, 2 Enterococcus durans isolates, 1 viridans group streptococcus, 1 group A streptococcus, and 1 Bacillus sp. 

^cNS, not significant (P > 0.050). 

^dIncludes four Escherichia coli, four Klebsiella pneumoniae, and three Serratia marcescens isolates and one isolate each of Citrobacter diversus, Enterobacter aerogenes, and Proteus mirabilis. 

^eIncludes one Pseudomonas aeruginosa isolate. 

^fIncludes four Clostridium septicum isolates, four Bacteroides thetaiotaomicron isolates, one Bacteroides fragilis isolate, one Bacteroides fragilis group isolate, one Bacteroides sp., and one Fusobacterium sp. 

^gIncludes four Candida parapsilosis, three Candida tropicalis, two Candida albicans, and two Candida glabrata isolates and one Histoplasma capsulatum isolate. 

Significantly more contaminants were recovered from Plus Anaerobic/F bottles than from Standard Anaerobic/F bottles (P < 0.001) (Table 6). For specific contaminant microorganisms, significantly more coagulase-negative staphylococci (P < 0.001) were recovered from Plus Anaerobic/F bottles, whereas significantly more enterococci (P < 0.05) and Propionibacterium spp. (P < 0.001) were recovered from Standard Anaerobic/F bottles. There were no significant differences in false-positive instrument signals between the two anaerobic bottles.

TABLE 6.

Comparative recovery of contaminants from BACTEC Plus Anaerobic/F and Standard Anaerobic/F blood culture bottles

Microorganism	No. of contaminants recovered from:			P
	Both bottles	Plus Anaerobic/F bottles only	Standard Anaerobic/F bottles only
Gram-positive cocci
Coagulase-negative staphylococci	113	168	59	<0.001
Enterococcia	3	1	8	<0.05
Other gram-positive coccib	4	14	9	NSc
Propionibacterium spp.	1	0	14	<0.001
Other microorganismsd	4	6	18	NS
All microorganisms	125	189	108	<0.001

^aIncludes 13 Enterococcus faecalis isolates and 1 Enterococcus faecium isolate. 

^bIncludes 16 viridans group streptococci, 8 Staphylococcus aureus isolates, and 3 nonhemolytic streptococci. 

^cNS, not significant (P > 0.050). 

^dIncludes seven diphtheroids, five anaerobic diphtheroids, three Bacillus spp., two Cornybacterium spp., two Lactobacillus spp., two Propionibacterium acnes isolates, two Veillonella parvula isolates, one Clostridium paraputrificum isolate, one Peptostreptococcus sp., one Bacteroides intermedius isolate, one Lactobacillus acidophilus isolate, and one yeast whose species was not determined. 

DISCUSSION

The debate as to the diagnostic yield and cost-effectiveness of anaerobic blood culture bottles continues. The purpose (and design) of this study was not to resolve that issue, which can be resolved only by controlled clinical trials comparing the yields of the best aerobic bottle against the best anaerobic bottle available with a specific blood culture system. Rather, the purpose of this study was to compare the yield and speed of detection of microbial growth of two anaerobic blood culture bottles available for use with the BACTEC 9000 series blood culture instruments.

In the present study, significantly more pathogenic microorganisms were recovered from Plus Anaerobic/F bottles than from Standard Anaerobic/F bottles. Recovery of not only all microorganisms combined but also several groups of bacteria was higher with Plus Anaerobic/F bottles. Plus Anaerobic/F bottles also had a superior ability to detect septic episodes and had an enhanced recovery of pathogenic microorganisms from patients receiving antimicrobial therapy at the time that blood was drawn for culture. Last, when the yields from either of the two anaerobic bottles paired with Plus Aerobic/F bottles were analyzed, the combination of Plus Aerobic/F and Plus Anaerobic/F bottles showed better recovery than the combination of Plus Aerobic/F and Standard Anaerobic/F bottles.

Only gram-negative anaerobic bacteria were recovered more often from Standard Anaerobic/F bottles than from Plus Anaerobic/F bottles. The reason(s) for this pattern of recovery is unknown. It is possible that the pattern would have been similar for other anaerobic bacteria had there been a sufficient number of isolates to permit a valid statistical comparison. Even without such data, however, it could be hypothesized that Standard Anaerobic/F bottles may provide a stricter anaerobic environment, thereby increasing the rate of recovery of strict anaerobes. This hypothesis is supported by the observation that there was a trend toward superior recovery of strict aerobes in Plus Anaerobic/F bottles.

The superior recovery from Plus Anaerobic/F bottles parallels that reported for other blood culture bottles containing resins or similar additives (2, 9, 10, 18, 22, 24). In controlled clinical trials these additives have been shown to improve microbial recovery, particularly for staphylococci (10, 20, 24, 25, 26, 28, 29). The mechanism(s) by which these additives increase microbial recovery is unknown. With the earlier BACTEC systems (e.g., BACTEC 460, 660, 730, and 860), one postulated mechanism of increased recovery was mechanical cell lysis caused by rapid agitation and a shearing effect of the glass beads within the broth medium (D. L. Jungkind, M. Thakur, and J. Dyke, Abstr. 89th Annu. Meet. Am. Soc. Microbiol. 1989, abstr. C 225, p. 431, 1989). Because continuous monitoring blood culture systems use a more gentle agitation mechanism, this mechanism of cellular lysis may not account for increased microbial recovery. There are only limited data to support an alternative hypothesis, namely, that these products bind to and inactivate antimicrobial agents within blood specimens. Data that support this hypothesis come from studies that have demonstrated increased recovery of staphylococci from patients receiving antistaphylococcal therapy (29). In the current study, such an effect was seen with Staphylococcus aureus and coagulase-negative staphylococci, but it was also seen with members of the family Enterobacteriaceae and all microorganisms combined. It also has been hypothesized that resins and other similar products bind to and inactivate nonspecific inhibitory factors in blood, thereby improving microbial recovery, but there are no published data to support this hypothesis. Moreover, any assessment of the effect on nonspecific inhibitors in blood needs to be separated from that of sodium polyanetholesulfonate, the anticoagulant used in BACTEC and most other commercial blood culture bottles. This agent inactivates lysozyme and complement, but it is not known whether this characteristic improves microbial recovery. Thus, the reason(s) for the pattern of increased recovery seen with resins and other similar products remains enigmatic.

Even though paired Plus Aerobic/F and Plus Anaerobic/F bottles showed enhanced yields in this study, whether or not use of such bottles is cost-effective or is an optimal diagnostic strategy has yet to be determined. First, Plus Aerobic/F and Plus Anaerobic/F bottles cost more than standard bottles. Because up to 90% of blood cultures are negative, much of the higher cost of Plus Aerobic/F and Plus Anaerobic/F bottles would not be offset by incremental gains in microbial recovery or improved patient care. Second, resin-containing bottles have been shown to yield more contaminants (10, 12, 25). Increased recovery of contaminants results in increased patient care and laboratory costs, offsetting, in part, any advantage of increased microbial recovery (1). Last, conclusions regarding the relative cost-effectiveness of different blood culture bottles or systems must be based on data collected specifically for that purpose.

Increased recovery of microorganisms from Plus Aerobic/F and Plus Anaerobic/F bottles for patients receiving antimicrobial therapy at the time of culture was also observed during this study. One possible explanation for this observation is that resins bind to and inactivate antimicrobial agents present in blood. In another study, the most pronounced increase in recovery was for patients with Staphylococcus aureus bacteremia who were receiving specific antistaphylococcal therapy at the time of culture (29). In this study, in addition to the observed increase in the rate of recovery of staphylococci, there was increased rate of recovery of members of the family Enterobacteriaceae and all microorganisms combined. Moreover, this pattern of recovery did not occur for patients who were not receiving antimicrobial therapy at the time of culture. Although the best explanation is that resins bind to and inactivate antimicrobial agents in blood, much remains to be explained about the pattern of increased recovery observed when media containing resins are used.

In summary, data from the present study demonstrate that microbial recovery from paired Plus Aerobic/F and Anaerobic/F bottles is superior to that from paired Plus Aerobic/F and Standard Anaerobic/F bottles. What has yet to be demonstrated is whether this enhanced recovery offsets the higher cost of Plus Aerobic/F and Plus Anaerobic/F bottles or whether use of an alternative companion bottle (8) is a better strategy for the recovery of pathogenic bacteria and fungi from blood.